Highland Capital Partners

One Broadway 14TH Floor
Cambridge, MA 2142

Firm Size

• Assets Under Management (AUM):$1 Billion
• Number of Funds:20
• Employees:
• Firm Type:Venture Capital
• Focus Areas: Software & Technology
  Services
  Healthcare
  Consumer
  

Description

Highland Capital Partners is a venture capital firm based in Cambridge, Massachusetts. Founded in 1988, the firm primarily invests in technology and healthcare companies at various stages of growth. With a focus on early-stage and growth-stage investments, Highland Capital Partners provides funding, strategic guidance, and operational support to help companies reach their full potential. The firm typically invests between $1 million and $25 million in each company, and its portfolio includes a variety of sectors such as software, internet, healthcare services, biotechnology, and consumer products. Highland Capital Partners has a strong reputation for its expertise and successful track record in identifying promising start-ups and working closely with entrepreneurs to help them scale their businesses. The firm's team of experienced professionals ensures that portfolio companies receive valuable guidance and access to the resources necessary for growth. In addition to its financial investments, Highland Capital Partners also offers entrepreneurs access to its extensive network of industry connections. This network includes relationships with other venture capital firms, industry experts, and potential customers, which can greatly benefit companies in their pursuit of market dominance and expansion opportunities. Overall, Highland Capital Partners plays a vital role in the vibrant start-up ecosystem of Cambridge, Massachusetts, providing both financial resources and strategic support to help innovative companies thrive and succeed.

Latest News

Powered by

Jun 05, 2024: Eko Health Raises $41 Million to Scale AI-Driven Heart and Lung Disease Detection
Eko Health , a pioneer in applying artificial intelligence for early detection of heart and lung diseases, today announced it has raised $41 million in Series D financing. With participation by ARTIS Ventures, Highland Capital Partners, NTTVC, and Questa Capital, the funding round will be used to expand U.S. and global access to the company's early disease detection platform.